Literature DB >> 31433478

Use of Prediction Intervals in Network Meta-analysis.

Lifeng Lin1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31433478      PMCID: PMC6707007          DOI: 10.1001/jamanetworkopen.2019.9735

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Network meta-analysis (NMA) is an increasingly popular tool to synthesize direct and indirect evidence for simultaneously comparing multiple treatments. Although guidelines have been developed to improve NMAs,[1] the quality of methodology and reporting of many NMAs is inconsistent with the rapid growth of their publication rates.[2] Within the context of conventional pairwise meta-analyses, it has been advocated to routinely report 95% prediction (or predictive) intervals (PIs) alongside 95% CIs.[3,4] Prediction intervals give the range within which the results of a future study might lie. They can also be used to effectively appraise heterogeneity and avoid the problems of the popular I2 statistic.[5] However, the practice of using PIs is uncommon in NMAs. As in conventional meta-analyses, heterogeneity frequently exists in NMAs owing to differences in study setting, participants, treatment definitions, and so on. This may affect the validity and interpretation of the NMA. To account for heterogeneity, random-effects models are usually applied, and evidence users often focus on the summarized overall results with 95% CIs. Confidence intervals and PIs are used for different purposes. Suppose an NMA compares multiple treatments for obesity, with its primary outcome as weight loss. Confidence intervals describe uncertainty in overall weight loss for various treatment comparisons among the populations in the NMA. As such, their widths typically shrink toward 0 as the number of studies increases. In addition to uncertainty in overall results, PIs’ widths incorporate the variation caused by heterogeneity between different studies. When a new patient comes to the clinic, PIs (rather than CIs) should be used to predict the new patient’s weight loss and thus recommend the optimal treatment.

Methods

To investigate the use of PIs in NMAs, relevant articles published in JAMA, The Lancet, and BMJ from January 1, 2010, to December 31, 2018, were identified. Full-length articles with original data were the focus. The search procedures are provided in eAppendix 1 in the Supplement. This study did not require institutional review board approval because it focuses on statistical methods and uses published data in the literature. Its reporting follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. In addition, to help clinicians understand how PIs can be produced in NMAs, available software programs and their implementations were illustrated via a worked example. This example used a classic NMA data set initially reported by Hasselblad[6] and based on 24 studies. This NMA compared 4 treatments for smoking cessation (a binary outcome) as follows: (1) no intervention, (2) self-help, (3) individual counseling, and (4) group counseling.[6] The estimated overall odds ratios of all treatment comparisons with 95% CIs and 95% PIs are reported. Statistical significance was prespecified at α = .05.

Results

Fifty-eight full-length articles on NMAs with original data were identified (eTable 1 in the Supplement). JAMA, The Lancet, and BMJ published 12 (21%), 11 (19%), and 35 (60%) NMA articles, respectively. Only 5 articles (9%) reported PIs, all published in BMJ. Software programs for producing PIs in NMAs appear in eTable 2 in the Supplement. Detailed instructions and results using these software programs appear in eAppendix 2 and the eFigure in the Supplement. The Figure shows the results of the NMA of smoking cessation using Stata version 13 (StataCorp). The 95% CIs of individual counseling vs no intervention and group counseling vs no intervention were above the null value 1.0. The overall treatment effects of individual counseling and group counseling were significantly better than no intervention among the 24 studies; they led to higher smoking cessation rates. The remaining 4 comparisons were nonsignificant. Nevertheless, the 95% PIs of all comparisons were wider than the corresponding 95% CIs and contained 1.0; thus, they indicated substantial heterogeneity between studies. Owing to such heterogeneity, the overall effects of individual counseling and group counseling could be null or even in the opposite direction for patients in a new study.[4]
Figure.

Estimated Overall Odds Ratios of 6 Treatment Comparisons in the Network Meta-analysis of Smoking Cessation Using Stata

Centers of boxes indicate odds ratios, with edges representing 95% CIs. Whiskers represent 95% prediction intervals (PIs).

Estimated Overall Odds Ratios of 6 Treatment Comparisons in the Network Meta-analysis of Smoking Cessation Using Stata

Centers of boxes indicate odds ratios, with edges representing 95% CIs. Whiskers represent 95% prediction intervals (PIs).

Discussion

A limitation of this study is that detailed statistical models used in different software programs were not explored. They may make different assumptions and thus have some impact on the NMA results (eFigure in the Supplement). In summary, the reporting rate of PIs was low among NMAs, but they are crucial for interpreting results within a future study setting and have been advocated for conventional meta-analyses. The low reporting rate was possibly because most NMA guidelines lack recommendations about PIs and performing NMAs is relatively complicated. Nevertheless, as shown in the worked example, several software programs are available to feasibly produce PIs in NMAs.
  6 in total

1.  Meta-analysis of multitreatment studies.

Authors:  V Hasselblad
Journal:  Med Decis Making       Date:  1998 Jan-Mar       Impact factor: 2.583

2.  Basics of meta-analysis: I2 is not an absolute measure of heterogeneity.

Authors:  Michael Borenstein; Julian P T Higgins; Larry V Hedges; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2017-01-06       Impact factor: 5.273

3.  Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review.

Authors:  Fernanda S Tonin; Helena H Borba; Leticia P Leonart; Antonio M Mendes; Laiza M Steimbach; Roberto Pontarolo; Fernando Fernandez-Llimos
Journal:  Int J Epidemiol       Date:  2019-04-01       Impact factor: 7.196

4.  Interpretation of random effects meta-analyses.

Authors:  Richard D Riley; Julian P T Higgins; Jonathan J Deeks
Journal:  BMJ       Date:  2011-02-10

5.  The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.

Authors:  Brian Hutton; Georgia Salanti; Deborah M Caldwell; Anna Chaimani; Christopher H Schmid; Chris Cameron; John P A Ioannidis; Sharon Straus; Kristian Thorlund; Jeroen P Jansen; Cynthia Mulrow; Ferrán Catalá-López; Peter C Gøtzsche; Kay Dickersin; Isabelle Boutron; Douglas G Altman; David Moher
Journal:  Ann Intern Med       Date:  2015-06-02       Impact factor: 25.391

6.  Plea for routinely presenting prediction intervals in meta-analysis.

Authors:  Joanna IntHout; John P A Ioannidis; Maroeska M Rovers; Jelle J Goeman
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

  6 in total
  6 in total

1.  A Bayesian approach to assessing small-study effects in meta-analysis of a binary outcome with controlled false positive rate.

Authors:  Linyu Shi; Haitao Chu; Lifeng Lin
Journal:  Res Synth Methods       Date:  2020-06-17       Impact factor: 5.273

2.  A penalization approach to random-effects meta-analysis.

Authors:  Yipeng Wang; Lifeng Lin; Christopher G Thompson; Haitao Chu
Journal:  Stat Med       Date:  2021-11-18       Impact factor: 2.373

3.  Empirical assessment of prediction intervals in Cochrane meta-analyses.

Authors:  Fahad M Al Amer; Lifeng Lin
Journal:  Eur J Clin Invest       Date:  2021-02-27       Impact factor: 5.722

4.  A Guide to Estimating the Reference Range From a Meta-Analysis Using Aggregate or Individual Participant Data.

Authors:  Lianne Siegel; M Hassan Murad; Richard D Riley; Fateh Bazerbachi; Zhen Wang; Haitao Chu
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

5.  Predictive P-score for treatment ranking in Bayesian network meta-analysis.

Authors:  Kristine J Rosenberger; Rui Duan; Yong Chen; Lifeng Lin
Journal:  BMC Med Res Methodol       Date:  2021-10-17       Impact factor: 4.615

6.  Estimating the reference range from a meta-analysis.

Authors:  Lianne Siegel; M Hassan Murad; Haitao Chu
Journal:  Res Synth Methods       Date:  2020-09-13       Impact factor: 5.273

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.